World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
12026
World Ranking
4672
National Ranking
101

Ennio De Gregorio publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ennio De Gregorio sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 67 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ennio De Gregorio D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ennio De Gregorio sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ennio De Gregorio is affiliated with Novartis in Switzerland and conducts research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work bridges several subfields, including Oncology, Infectious Diseases, Health, Modeling and Simulation, and Genetics.

Their research covers a variety of topics, notably in SARS-CoV-2 and COVID-19 research, vaccine coverage and hesitancy, COVID-19 epidemiological studies, genetic and kidney cyst diseases, renal and related cancers, fetal and pediatric neurological disorders, and CAR-T cell therapy research.

Ennio De Gregorio has published studies in several scientific venues. These include:

  • Proceedings of the National Academy of Sciences
  • Stem Cell Research
  • EJC Skin Cancer

Their recent papers reflect a focus on immunology, stem cell research, and cancer diagnostics:

  • "Vaccinology in the post−COVID-19 era," 2021, Proceedings of the National Academy of Sciences
  • "Production and characterisation of four Joubert syndrome patient-derived induced pluripotent stem cell (iPSC) lines with mutations in either RPGRIP1L or CPLANE1 genes," 2025, Stem Cell Research
  • "Targeting CD146 and CD271 in melanoma circulating tumour cells: advancing liquid biopsy technologies," 2025, EJC Skin Cancer

Collaborations feature several frequent coauthors, including Rino Rappuoli, Giuseppe Del Giudice, Sanjay Phogat, Simone Pecetta, and Mariagrazia Pizza. These recurrent partnerships suggest an interdisciplinary approach linking vaccine development, molecular biology, and oncology.

Best Publications

  • The Toll and Imd pathways are the major regulators of the immune response in Drosophila

    Ennio De Gregorio;Paul T. Spellman;Phoebe Tzou;Gerald M. Rubin

  • Genome-wide analysis of the Drosophila immune response by using oligonucleotide microarrays.

    Ennio De Gregorio;Paul T. Spellman;Gerald M. Rubin;Bruno Lemaitre

  • New adjuvants for human vaccines.

    M Lamine Mbow;Ennio De Gregorio;Nicholas M Valiante;Rino Rappuoli

  • Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.

    Samuele Calabro;Marco Tortoli;Barbara C. Baudner;Alessandra Pacitto

  • Vaccines for the 21st century.

    Isabel Delany;Rino Rappuoli;Ennio De Gregorio

  • How Drosophila combats microbial infection: a model to study innate immunity and host-pathogen interactions.

    Phoebe Tzou;Ennio De Gregorio;Bruno Lemaitre

  • Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

    Rino Rappuoli;Matthew J. Bottomley;Ugo D’Oro;Oretta Finco

  • An immune-responsive Serpin regulates the melanization cascade in Drosophila.

    Ennio De Gregorio;Sung Jun Han;Won Jae Lee;Min Ji Baek

  • Vaccines, new opportunities for a new society

    Rino Rappuoli;Mariagrazia Pizza;Giuseppe Del Giudice;Ennio De Gregorio

  • Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants

    Charles Maisonneuve;Sylvie Bertholet;Dana J. Philpott;Ennio De Gregorio

  • Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders

    Domenico Rosa;Giulietta Saletti;Ennio De Gregorio;Francesca Zorat

  • The path to a successful vaccine adjuvant--'the long and winding road'.

    Derek T. O’Hagan;Ennio De Gregorio

  • Alum adjuvanticity: Unraveling a century old mystery

    Ennio De Gregorio;Elaine Tritto;Rino Rappuoli

  • Mechanism of action of licensed vaccine adjuvants.

    Elaine Tritto;Flaviana Mosca;Ennio De Gregorio

  • From empiricism to rational design: a personal perspective of the evolution of vaccine development

    Ennio De Gregorio;Rino Rappuoli

  • Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens.

    Niels Peter H. Knudsen;Anja Olsen;Cecilia Buonsanti;Frank Follmann

  • Rapidly produced SAM ® vaccine against H7N9 influenza is immunogenic in mice

    Armin Hekele;Sylvie Bertholet;Jacob Archer;Daniel G Gibson

  • Technologies to address antimicrobial resistance.

    Stephen J. Baker;David J. Payne;Rino Rappuoli;Ennio De Gregorio

  • The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.

    Samuele Calabro;Elaine Tritto;Annamaria Pezzotti;Marianna Taccone

  • Translation driven by an eIF4G core domain in vivo.

    Ennio De Gregorio;Thomas Preiss;Matthias W. Hentze

  • Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88

    Anja Seubert;Samuele Calabro;Laura Santini;Barbara Galli

  • Erratum: Vaccines for the twenty-first century society

    Rino Rappuoli;Christian W. Mandl;Steven Black;Ennio De Gregorio

Frequent Co-Authors

Rino Rappuoli
Rino Rappuoli Imperial College London
Derek O'hagan
Derek O'hagan GlaxoSmithKline (United Kingdom)
Nicholas M. Valiante
Nicholas M. Valiante Novartis (Switzerland)
Andreas Wack
Andreas Wack The Francis Crick Institute
Jeffrey B. Ulmer
Jeffrey B. Ulmer Novartis (Switzerland)
Bruno Lemaitre
Bruno Lemaitre École Polytechnique Fédérale de Lausanne
Guido Grandi
Guido Grandi University of Trento
Manmohan Singh
Manmohan Singh Beam Therapeutics
Matthias W. Hentze
Matthias W. Hentze European Molecular Biology Laboratory
Christian W. Mandl
Christian W. Mandl Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare degrees can broaden career prospects. Many students consider accelerated nursing programs as a quick pathway to enter the clinical field while building a foundation in patient care and biomedical sciences. Programs designed for fast admission, such as easy admission lpn programs, provide accessible entry points for those pursuing practical nursing careers alongside immunology knowledge.

Nurse practitioner roles are expanding rapidly, especially in specialized fields like immunology and infectious diseases. Joining the ranks through the easiest nurse practitioner degree programs can make the transition smoother for professionals aiming to advance clinical expertise and leadership capabilities in healthcare settings.

For mental health focus integrated with immunological research or care, top online pmhnp programs with best clinical placement rates offer excellent training and practical experiences. These programs ensure that students receive hands-on opportunities crucial for mental health and immunology crossover roles in healthcare institutions.

Each of these pathways not only complements an immunology background but also enhances job readiness in a competitive healthcare environment. Prospective students should carefully consider program structure, clinical opportunities, and admission criteria to align their education with long-term career goals.

Best Scientists Citing Ennio De Gregorio

Trending Scientists

Recently Published Articles